Garry R. Smith

1.4k total citations
37 papers, 858 citations indexed

About

Garry R. Smith is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Garry R. Smith has authored 37 papers receiving a total of 858 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Organic Chemistry and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Garry R. Smith's work include Chemical Synthesis and Analysis (7 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Carbohydrate Chemistry and Synthesis (6 papers). Garry R. Smith is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Carbohydrate Chemistry and Synthesis (6 papers). Garry R. Smith collaborates with scholars based in United States, Netherlands and France. Garry R. Smith's co-authors include Allen B. Reitz, Arpad Z. Szarka, Robin M. Hochstrasser, Roseanne J. Sension, Michael H. Parker, Scott M. Rawls, Harold G. Selnick, Andrew J. Tebben, Christopher S. Tallarida and Ryan A. Gregg and has published in prestigious journals such as Circulation, Journal of Medicinal Chemistry and Chemical Physics Letters.

In The Last Decade

Garry R. Smith

37 papers receiving 832 citations

Peers

Garry R. Smith

CMN

TOXIC

Vladimı́r Setnička Czechia

Michael T. Scerba United States

S. E. Wolkenberg United States

Hitoshi Uno Japan

Jennifer E. Davoren United States

K. W. Bentley United States

Charles F. Barfknecht United States

Alexandre V. Ivachtchenko Russia

Rosario Herranz Spain

Mark P. Wentland United States

Vladimı́r Setnička Czechia

Garry R. Smith

245 ×0.7

602 ×2.2

78 ×0.5

CMN

128 ×0.9

53 ×0.5

TOXIC

Citations per year, relative to Garry R. Smith Garry R. Smith (= 1×) peers Vladimı́r Setnička

Countries citing papers authored by Garry R. Smith

Since Specialization

Citations

This map shows the geographic impact of Garry R. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry R. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry R. Smith more than expected).

Fields of papers citing papers by Garry R. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry R. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry R. Smith. The network helps show where Garry R. Smith may publish in the future.

Co-authorship network of co-authors of Garry R. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Garry R. Smith. A scholar is included among the top collaborators of Garry R. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry R. Smith. Garry R. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oliver, Chicora F., et al.. (2018). Chemokines and ‘bath salts’: CXCR4 receptor antagonist reduces rewarding and locomotor-stimulant effects of the designer cathinone MDPV in rats. Drug and Alcohol Dependence. 186. 75–79. 19 indexed citations

Hicks, Callum, Ryan A. Gregg, Lee Anne Cannella, et al.. (2017). Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG). Psychopharmacology. 234(11). 1671–1681. 20 indexed citations

Gregg, Ryan A., Callum Hicks, Christopher S. Tallarida, et al.. (2016). Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator. Neuropharmacology. 108. 111–119. 28 indexed citations

Bompiani, Kristin M., et al.. (2016). High-Throughput Screening Uncovers Novel Botulinum Neurotoxin Inhibitor Chemotypes. ACS Combinatorial Science. 18(8). 461–474. 2 indexed citations

Smith, Garry R., et al.. (2015). Synthesis of lemonose derivatives: methyl 4-amino-3-O,4-N-carbonyl-2,4,6-trideoxy-3-C-methyl-α-l-lyxo-pyranoside and its phenyl thioglycoside. Carbohydrate Research. 409. 63–68. 6 indexed citations

Gregg, Ryan A., Christopher S. Tallarida, Robert B. Raffa, et al.. (2014). Stereochemistry and neuropharmacology of a ‘bath salt’ cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates. Neuropharmacology. 91. 109–116. 18 indexed citations

McDonnell, Mark E., Jay Wrobel, Garry R. Smith, et al.. (2014). Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(4). 1116–1121. 15 indexed citations

Smith, Garry R., Douglas E. Brenneman, Yan Zhang, Yanming Du, & Allen B. Reitz. (2013). Small-Molecule Anticonvulsant Agents with Potent In Vitro Neuroprotection and Favorable Drug-Like Properties. Journal of Molecular Neuroscience. 52(3). 446–458. 6 indexed citations

Smith, Garry R., Dejan Caglič, Petr Čapek, et al.. (2012). Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: Extending towards the β-exosite. Bioorganic & Medicinal Chemistry Letters. 22(11). 3754–3757. 12 indexed citations

10.

Brenneman, Douglas E., Garry R. Smith, Yan Zhang, et al.. (2012). Small Molecule Anticonvulsant Agents with Potent In Vitro Neuroprotection. Journal of Molecular Neuroscience. 47(2). 368–379. 8 indexed citations

11.

McDonnell, Mark E., Matthew D. Vera, Benjamin E. Blass, et al.. (2012). Riluzole prodrugs for melanoma and ALS: Design, synthesis, and in vitro metabolic profiling. Bioorganic & Medicinal Chemistry. 20(18). 5642–5648. 24 indexed citations

12.

Reitz, Allen B., Garry R. Smith, & Michael H. Parker. (2009). The role of sulfamide derivatives in medicinal chemistry: a patent review (2006 – 2008). Expert Opinion on Therapeutic Patents. 19(10). 1449–1453. 67 indexed citations

13.

Stump, Gary L., Garry R. Smith, Andrew J. Tebben, et al.. (2003). In Vivo Canine Cardiac Electrophysiologic Profile of 1,4-Benzodiazepine Iks Blockers. Journal of Cardiovascular Pharmacology. 42(1). 105–112. 15 indexed citations

14.

Smith, Garry R. & Robert M. Giuliano. (1999). Synthesis of methyl α-l-vancosaminide. Carbohydrate Research. 323(1-4). 208–212. 6 indexed citations

15.

Selnick, Harold G., Garry R. Smith, & Andrew J. Tebben. (1995). An Improved Procedure for the Cyanation of Aryl Triflates: A Convenient Synthesis of 6-Cyano-1,2,3,4-Tetrahydroisoquinoline. Synthetic Communications. 25(20). 3255–3261. 35 indexed citations

16.

Giuliano, Robert M., et al.. (1995). Carbohydrate N-phosphinyl imine derivatives: synthesis and conversion to amino sugars. Carbohydrate Research. 278(2). 345–350. 2 indexed citations

17.

Dorland, L., et al.. (1990). O-Phosphohydroxylysinuria: a new inborn error of metabolism?. Clinica Chimica Acta. 188(3). 221–226. 4 indexed citations

18.

King, F. E., JW Clark-Lewis, & Garry R. Smith. (1954). Syntheses from phthalimido-acids. Part V. Amides of glycine, DL-alanine, and L-glutamic acid with amphetamine, benzocaine, and procaine. Journal of the Chemical Society (Resumed). 1044–1044. 2 indexed citations

19.

King, F. E., JW Clark-Lewis, & Garry R. Smith. (1954). Syntheses from phthalimido-acids. Part VI. Further products from phthalyl-DL-aspartic anhydride, and the preparation of phthalylglycyl-DL-asparagine and -DL-serine. Journal of the Chemical Society (Resumed). 1046–1046. 2 indexed citations

20.

King, F. E., et al.. (1954). Syntheses from phthalimido-acids. Part IV. p-Glycylaminobenzoic acid and derivatives. Journal of the Chemical Society (Resumed). 1039–1039. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact